Hospital-Acquired Infection Diagnostics Market Research Report by Leading Key Players- AstraZeneca, Bayer, Daiichi Sankyo, Danaher, Hologic, Johnson & Johnson, Roche

Hospital-acquired infection (H AI) diagnostics market is forecasted to reach $4,386.6 million by 2023, growing at a CAGR of 7.6% during 2017–2023, P&S Market Research.The growth in the market will be led by the increase in incidences of infections caused in clinical settings, especially in developing economies owing to their poor hygiene facilities.

On the basis of test type, the HAI diagnostics industry has been categorized molecular diagnostics, urinalysis, and immunoassay. Due to the high prevalence rate of HAI such as, bloodstream infections, surgical site infections, gastrointestinal Infections, and urinary tract infections (UTI), the immunoassay segment was the highest contributor accounting for $1,195.0 million in 2016 and is expected to reach $1,686.2 million by 2023.

Browse Detailed Report Summary with In-depth TOC on : https://www.psmarketresearch.com/market-analysis/hospital-acquired-infection-diagnostics-market

HAI are caused by viral, bacterial, and fungal pathogens; the most common types are bloodstream infection (BSI), pneumonia including, ventilator-associated pneumonia (VAP), urinary tract infection (UTI), and surgical site infection (SSI). Urinary Tract Infections (UTI) segment has dominated the HAI diagnostics market, whereas gastrointestinal infections have registered highest growth rate registering a CAGR of 9.6% throughout the forecast period.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/hospital-acquired-infection-diagnostics-market/report-sample

Hospitals are the largest end users to the HAI diagnostics market, estimated to generate a revenue of $1,021.3 million, in 2017. Clinics, ambulatory surgical centers, and others end users contributing to the HAI diagnostics industry.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=hospital-acquired-infection-diagnostics-market

Key players in the HAI diagnostics industry are acquiring other players, to gain a larger market share. For instance, in October 2017, Abbott Laboratories intends to close the acquisition of Alere Inc. The announcement follows receipt of all regulatory clearances necessary for closing. The acquisition is intended to expand Abbott Laboratories global point of care testing portfolio. Similarly, in April 2017, Becton, Dickinson and Company announced the acquisition of Caesarea Medical Electronics, an Israel based global infusion pump systems manufacturer. The acquisition would expand Infusion Portfolio for ambulatory, home care and specialty applications.

About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.